Here’s how I’d invest £200 per month in an ISA starting right now

Want to get involved in the market recovery? Here’s how I’d invest in growth and income shares in an ISA.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

A lot of investment advice makes the point that it is important to invest regularly and to start as early as possible. This is why I’d be keen to invest a sum like £200 in an ISA right now. The market is also recovering from the March crash and this situation could well continue, enabling investors to make gains in the short-term. 

Investing in an ISA

When investing a relatively small amount of money I’d want it to grow over time. One of the best ways to achieve growth is to collect dividends and the reinvest them in more shares. This creates a nice cycle where you have ever more shares paying ever more income and hopefully growing in value as well.

The double engine of share price growth with dividend income can really boost an investor’s finances. But it’s very important to take the leap and get started. Doing so at a time then market is growing could give a confidence boost that’s essential for long-term investing.

So I’d use my £200 to invest in FTSE 100 shares that are still paying a dividend and likely to keep doing so. I’d also want the company to have decent growth prospects and not be in a declining industry like tobacco.

Shares for an ISA

There are two shares that come to mind and meet these criteria. One is the pharmaceutical giant GlaxoSmithKline (LSE: GSK). It has held its dividend flat, which is a very fortunate decision in retrospect. It has done this to invest in R&D which will be vital to developing new blockbuster drugs.

It’s also reorganising and selling off the consumer part of the business. This will make it a closer rival to AstraZeneca, which has done extremely well in recent years. It recently became the most valuable FTSE 100 company.

Even though the dividend has been held flat for several years, the shares still have a 4.8% dividend yield. I think investing in GlaxoSmithKline is a good way to get defensive shares. This kind of share should rise regardless of what happens to the economy.

Shares in Legal & General (LSE:LGEN) are both cheaper and high yielding than GSK’s. The company has become a force to be reckoned with in the pensions industry – a definite growth market given the greying population.

Legal & General has committed to keep paying its dividend, despite pressure from the regulator and many of its rivals, including Aviva, suspending theirs.

The group has been shown strong growth in revenue and operating profits. Even so, the shares have been hit during the market sell-off. This is because it is seen as a financial stock, and financial stocks are generally at greater risk in a falling economy.

However, I’m not sure that the economy has a big effect on Legal & General. Its shares now yield over 8% and have a price-to-earnings of only 6. This is why I think the shares are ideal to invest in right now.

Andy Ross owns shares in Legal & General and AstraZeneca. The Motley Fool UK owns shares of and has recommended GlaxoSmithKline. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Santa Clara offices of NVIDIA
Investing Articles

£5,000 invested in Nvidia stock 6 months ago is now worth…

Nvidia stock's taking a breather at the moment. But it could be getting ready for its next move higher, says…

Read more »

British coins and bank notes scattered on a surface
Investing Articles

I hold Lloyds. Is it madness to buy Barclays shares too?

Harvey Jones is keen to buy Barclays shares but wonders whether he's simply doubling down, given that he already holds…

Read more »

Asian man looking concerned while studying paperwork at his desk in an office
Investing Articles

It’s time we all took a long, cold look at the Lloyds share price

The Lloyds share price has been good to Harvey Jones, making him a huge fan of the FTSE 100 bank.…

Read more »

Warren Buffett at a Berkshire Hathaway AGM
Investing Articles

Warren Buffett didn’t retire early. But could his investing wisdom help you do so?

Warren Buffett's wisdom from decades of stock market investing is actionable even for a modest investor who simply aims to…

Read more »

Young female hand showing five fingers.
Investing Articles

5 compelling investment ideas for a Stocks and Shares ISA in 2026

Edward Sheldon discusses some ideas to consider for a Stocks and Shares ISA and highlights a UK stock that could…

Read more »

Man writing 'now' having crossed out 'later', 'tomorrow' and 'next week'
Investing Articles

Is this the best time to buy shares in a long time?

Earlier this week, Bill Ackman stated on X that this is the best time to buy shares in a long…

Read more »

A senior man and his wife holding hands walking up a hill on a footpath looking away from the camera at the view. The fishing village of Polperro is behind them.
Investing Articles

£1,000 buys 35 shares in an incredibly reliable FTSE 100 dividend stock

Despite falling 72% from their highs, shares in this FTSE 100 company have been an incredibly reliable source of dividend…

Read more »

Warren Buffett at a Berkshire Hathaway AGM
Investing Articles

This is what Warren Buffett has to say about passive income — and I’m listening!

While searching for new ways to earn passive income, our writer takes to heart sage advice from the Oracle of…

Read more »